So what happened to people that got the C-19 , and now have the antibodies ?

This forum is to discuss general things concerning TSOI.
Posts: 3538
Joined: Fri Jun 26, 2020 5:22 am

So what happened to people that got the C-19 , and now have the antibodies ?

Post by trader32176 »

What happened to the people that got C-19, and now have the antibodies ?

1) Current science says you have antibodies for 11 months , after getting c-19.
2) there is no solid data that I can find on taking the vaccines , when someone has been infected , and has the antibodies.
3) there is not much data on repeat infection on C-19 patients.
User avatar
Posts: 2268
Joined: Fri Jun 26, 2020 4:36 am

Re: So what happened to people that got the C-19 , and now have the antibodies ?

Post by TimGDixon »

I think if you caught covid-19 naturally you will have antibodies 15 years from now. Vaccines we will be lucky if its a year.

Thats the difference between self and non-self immunity.

Edit: I should qualify that - in SarsCoV there are patients who had antibodies 17 years after infection. SarsCoV and SarsCoV2 are almost identical.
CoV_a-b copy.jpg
CoV_a-b copy.jpg (1.05 MiB) Viewed 1228 times
Last edited by TimGDixon on Thu Jun 17, 2021 11:57 am, edited 1 time in total.
Posts: 21
Joined: Wed Apr 28, 2021 5:45 am

Re: So what happened to people that got the C-19 , and now have the antibodies ?

Post by RR19 »

What if we had COVID 19 recovered with self immunity but also took vaccine later? Any thoughts?
User avatar
Posts: 2268
Joined: Fri Jun 26, 2020 4:36 am

Re: So what happened to people that got the C-19 , and now have the antibodies ?

Post by TimGDixon »

I think the vaccine is only against one of four genes involved in the sequencing of the virus - in that pic you see the Green boxes S,E,M,N. Thats the virus in its genetic source - the vaccine immunizes you against S which is a surface glycoprotein - but it does not immunize you against the other 3 nucleotides nor the sequenced living virus. But if you had natural infection you have immunity to the entire virus and therefore greater immunity over the vaccine and longer duration of antibodies.
Posts: 3538
Joined: Fri Jun 26, 2020 5:22 am

Re: So what happened to people that got the C-19 , and now have the antibodies ?

Post by trader32176 »

Rand Paul exposes total fraud, deception of Fauci and the CDC, who deliberately ignore NATURAL immunity

7/5/21 ... unity.html

Is Tony Fauci lying about Wuhan coronavirus (Covid-19) “vaccines” in an effort to hoodwink parents into getting their children injected? It would certainly seem that way.

Sen. Rand Paul of Kentucky agrees, having stated in a recent interview that none of the “experts” are following the science as they push to have all age groups, including babies, jabbed for Chinese Germs.

Truth be told, the chances of someone under the age of 25 dying from the Wuhan Flu is basically zero. And yet almost nobody in any position of authority is willing to acknowledge this fact.

“It’s hard to tell why the former president of the AMA (American Medical Association) wouldn’t know this knowledge,” Sen. Paul wondered about why nobody is speaking out against this travesty.

“When you’re there, though, it’s kind of like a pep rally. It’s a pep rally for getting everybody to take the vaccine and why everybody should do it. It’s not a thoughtful presentation about ‘these are the risks and the benefits, and this is why your risk of the disease is much greater.'”

The risk of testing “positive” for the Fauci Flu and subsequently dying is about one in a million. And yet the medical deep state is endlessly droning on about how everyone needs to get injected to help “flatten the curve.”

“They shouldn’t just tell us, ‘don’t think about it, just get vaccinated,'” Sen. Paul added about the misguided medical advice coming from the government.

“That’s what they’re doing. So, they’re not wanting to think about natural immunity. They don’t even read any of the articles. They don’t even collect the statistics.”

If someone already had covid, why would that person now need an injection?

Another thing that almost nobody is talking about is whether or not those who previously tested positive for the Chinese Virus in any way benefit from getting the jab.

Nobody is looking into the matter or trying to study it, instead resorting to just pushing the injections on everyone, regardless of age, health or previous infection status.

“When Dr. Fauci’s been asked how many people who have been vaccinated already had the disease first, he has no idea,” Sen. Paul says.

“Wouldn’t you want to study that? Because we’ve vaccinated so many people now. What if we vaccinated 50 million people who already had it? And they all seem to do okay but guess what? They all had worse side effects, and we measured a bunch of them and it turns out they had enough immunity after one vaccine, not two.”

Many independent scientists are beginning to come out of the woodwork to say that those who already had the Wuhan Flu probably do not need any kind of injection. And yet almost nobody on television or at the White House is suggesting this to the general public.

“There are a lot of scientists who are recommending that if you’re going to be vaccinated if you already had it, you probably only need one (injection),” Sen. Paul says about one approach to the situation.

“That’s probably without a doubt true, but nobody even looks at the science. The people in government aren’t even bothering to look because their head is in the sand and it’s like, ‘everybody just do the same, just do as you’re told.'”

It truly is a sad state of affairs when the people who are paid to be looking out for us have all devolved into collective pseudoscientific groupthink.
Posts: 3538
Joined: Fri Jun 26, 2020 5:22 am

Re: So what happened to people that got the C-19 , and now have the antibodies ?

Post by trader32176 »

Policymakers ignoring natural immunity to covid in favor of “vaccine” immunity

7/9/21 ... tions.html

When government officials and public health experts alike discuss herd immunity with regards to the Wuhan coronavirus (COVID-19), they usually talk about vaccinating as many people as possible. But as they push for vaccinations as the only way to achieve herd immunity against the coronavirus, there is one aspect they are willfully neglecting: natural immunity.

When a person gets infected with COVID-19 and recovers, that person has already defeated the infection and therefore already has natural immunity. This coronavirus survivor already has an immune system that is prepared to fight against future potential COVID-19 infections for the rest of his life. This means people with natural immunity do not need a vaccine.

Multiple studies show natural immunity good at preventing COVID-19

The idea that people with natural immunity do not need to get vaccinated against COVID-19 is supported by multiple studies.

In May, the World Health Organization (WHO) released a scientific update stating that people who have recovered from prior COVID-19 infections have developed a strong protective immune response. ... id19/92836

The WHO summarized its update by stating that within four weeks of infection, 90 to 99 percent of people who have recovered from the coronavirus can develop detectable neutralizing antibodies that can prevent any future infections. The WHO’s report said the immune system had “durable memories” of the virus up to eight months after the initial infection.

Another study published in the journal Nature in late May found that most people who were infected with the coronavirus had immunological memory of the disease in their bone marrow. This strongly suggests that people who have recovered from COVID-19 are still able to produce antibodies against it a year out.

A second study published in BioRxic found that cells known as “memory B” can fend off COVID-19 for at least 12 months after infection. This finding meshes well with the prior findings of the WHO and the study published in Nature. Memory B cells have been found to rapidly reproduce and generate coronavirus antibodies once it interacts with it again.

A third study from the Cleveland Clinic found that natural immunity to the coronavirus may be “as good as being vaccinated.” The researchers in this study followed more than 52,000 employees of the clinic for five months. Over 1,300 of the employees had prior COVID-19 infections and remained unvaccinated.

The researchers found that not a single one of the more than 1,300 employees with prior infections were reinfected during the five months that they were monitored. They concluded that people with laboratory-confirmed and symptomatic coronavirus infections are unlikely to benefit from vaccinations.

People with natural immunity could be discriminated against if they aren’t treated the same as vaccinated individuals

Dr. Jeffrey Klausner and Dr. Noah Kojima, writing for Medpage Today, noted that public health policymakers are ignoring “the complexities of the human immune system” in favor of maintaining discussions of supposed immunity from vaccinations.

“If SARS-CoV-2 immunity is similar to other severe coronavirus infections like SARS-CoV-1 immunity, that protection could last at least 17 years.” they wrote. “However, tests to measure cellular immunity are complex and expensive, making them hard to get and preventing their use in routine medical practice or in public health surveys of the population.”

If people with natural immunity against COVID-19 continue to be excluded from discussions regarding herd immunity, it could lead to disastrous consequences. Jon Sanders, writing for the American Institute for Economic Research, surmised that unvaccinated individuals with natural immunity could be discriminated against.

“People with natural immunity could be kept from employment, education, travel, normal commerce and who knows what other things if they don’t submit to a vaccine they don’t need in order to fulfill a headcount that confuses a means with the end,” wrote Sanders.

Klausner and Kojima recommend that moving forward, public health policymakers should include natural immunity as evidence of immunity “equal to that of vaccination.”

“That immunity should be given the same societal status as vaccine-induced immunity. Such a policy will greatly reduce anxiety and increase access to travel, events, family visits and more.”

This kind of policy focus will allow people who have recovered from COVID-19 access to the same privileges currently being enjoyed by vaccinated individuals.
Posts: 3538
Joined: Fri Jun 26, 2020 5:22 am

Re: So what happened to people that got the C-19 , and now have the antibodies ?

Post by trader32176 »

People Who Recover From COVID-19 At "Very Low Risk" Of Re-Infection: Study

7/10/21 ... tion-study

People who have contracted COVID-19 and recovered should know that the risk for re-infection is very low, a doctor said after a study he worked on was published.

Researchers analyzed records from Curative, a clinical laboratory based in San Dimas that specializes in COVID-19 testing and has during the pandemic been conducting routine workforce screening. None of the 254 employees who had COVID-19 and recovered became re-infected, while four of the 739 who were fully vaccinated contracted the disease.

“The big takeaway was that if you are not vaccinated, and were not previously infected, one, you have a very high risk getting infected—24 percent of employees over a year tested positive. However, on the flip side, if you were vaccinated or previously infected your risk was near zero,” Dr. Jeffrey Klausner, clinical professor of preventive medicine and medicine at the University of Southern California’s Keck School of Medicine, told The Epoch Times.

Klausner and Dr. Noah Kojima of the University of California, Los Angeles’ Department of Medicine joined with Curative workers to analyze the records. They released a pre-print, or pre-peer reviewed version of the study online this week.

Researchers found that of the 4,313 employees who were not previously infected or fully vaccinated, 254 became infected.

The findings add to the growing body of research that indicates people who had COVID-19 and recovered enjoy a similar level of protection as those who have gotten a vaccine, following a study in the United Kingdom - 7/3/21 ... 08/6314286

and one by Cleveland Clinic researchers - 6/9/21 ... 50989.html

“It should give confidence to people who have recovered that they are at very low risk for repeat infection and some experts including myself believe that protection is equal to vaccination,” Klausner told The Epoch Times.

“And we’re trying to update policy such that people who have recovered have the same privileges and access as people who are vaccinated.”

According to federal guidance, vaccines should be administered to people irrespective of whether they’ve had COVID-19 in the past.

The Centers for Disease Control and Prevention (CDC) has said officials are aware of evidence suggesting natural immunity among those who have been infected but has not altered its recommendations to incorporate that evidence.

“We do not comment on non-CDC authored papers. We continually evaluate the science that leads to our guidance, and if it needs to be changed, we will be base that on our own research and studies,” a spokesman told The Epoch Times in an email last month.

The limitations of the new study, which has been submitted to a journal and is being peer reviewed, include the possibility employees could have tested positive for COVID-19 outside of the routine screening, or employee testing program.

The group plans to conduct more analysis on the Curative data.

Dr. David Boulware, professor of medicine at the University of Minnesota, told The Epoch Times via email that the study “adds to the body of literature that generally healthy adults <65 years old with prior COVID-19 infection are generally not at risk of recurrent SARS-CoV-2 infection in short term after initial symptomatic infection.”

SARS-CoV-2 is another name for the CCP (Chinese Communist Party) virus, which causes COVID-19.

Boulware, who was not involved in the research, noted that the median age of those tested was 29 years old and very likely included few people 65 years old or older, or many people without immune system problems.

“Thus, this may not apply to elderly persons or persons with substantial co-morbidities—but does likely apply to adults 18-65 years of age without major medical problems,” he said, adding that because the follow-up time period of those studied was relatively short, the paper does not give insight into longer-term protection.

“Long term protection is more unknown, which is why persons with prior infection still are recommended to receive at least 1 vaccine dose, but there is not any urgency to receive the vaccine (and waiting ~3 months likely would be fine),” he said.

Klausner said that besides bolstering the idea of natural immunity, the study shows that vaccination in the workplace is important.

“We need to continue to promote workplace vaccination requirements. Businesses have the authority and have the ability and have the legal power to require employees get vaccinated,” he said. “And I think this did the support that benefits of that.”
Posts: 3538
Joined: Fri Jun 26, 2020 5:22 am

Re: So what happened to people that got the C-19 , and now have the antibodies ?

Post by trader32176 »

SARS-CoV-2 immunity due to prior infection or vaccination is similar, study says

7/11/21 ... -says.aspx

A new study published on the medRxiv* preprint server finds that the rate of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection is low following one episode of the infection. Breakthrough infections were also found to be similarly rare after vaccination with a messenger ribonucleic acid (mRNA) vaccine, say the researchers.


SARS-CoV-2, which was originally detected in Wuhan, China in December 2019, is the virus responsible for the devastating coronavirus disease 2019 (COVID-19). The impact of COVID-19, along with the comprehensive restrictions that have been placed on social interactions, has forced businesses and schools to close. As a result, millions of people around the world became unemployed, which has caused the global economy to suffer tremendously.

The continued urgency of the COVID-19 pandemic has led to unprecedented efforts to develop effective antivirals and vaccines to combat this virus. These efforts have led to the development of several safe and high efficacious vaccines that have since been approved for public use in many countries around the world. These vaccines promise a respite from the unending overload on healthcare staff and facilities.

The earliest vaccines to gain emergency use authorization included the mRNA vaccines from Pfizer/BioNTech and Moderna. The mRNA vaccines deliver viral genetic material encoding for the immunogenic viral spike (S) glycoprotein, which enters the cells of the vaccine recipient to activate the immune system.

How was the study performed?

The current study examined how vaccination compares with natural SARS-CoV-2 infection rates in its ability to reduce the rate of infection. This research was conducted by Curative, which is a company that specializes in SARS-CoV-2 testing. To this end, Curative began to test its employees using a reverse transcriptase-polymerase chain reaction (RT -PCR) method that was authorized by the United States Food and Drug Administration (FDA).

Daily testing was combined with an automated database that was implemented on May 8, 2020. To date, Curative is continuing to test its employees daily, even after vaccination campaigns began.

Among the three different groups of employees that were included in the current study, one was defined as the naïve unvaccinated group. This group, which consisted of over 4,300 records, remained applicable until December 15, 2020, which is when vaccination was offered to all employees.

The second group included unvaccinated individuals with a history of prior infection, which included 254 records. The third group, which consisted of almost 740 records, comprised vaccinated people from December 15, 2020, to July 1, 2021.

Any individual who had two positive RT-PCR tests was defined as having SARS-CoV-2 infection. The comparisons between the three groups were on the basis of the incidence rate ratio (IRR), defined as “the ratio of confirmed COVID-19 cases per 100 person-years.”

Did the incidence decrease after infection or vaccination?

Within the naïve group, approximately 26 new cases were reported per 100 person-years. In the second group, which consisted of previously infected and unvaccinated individuals, and the third group of vaccinated individuals, there were zero and 1.6 cases, respectively, per 100 person-years.

This implies an incident rate ratio (IRR) of zero following natural infection with the virus. That is, when the incidence among those with a history of infection (zero) is compared to that among the naïve individuals (26), the former have no risk of reinfection.

Conversely, the IRR was 0.06 when the incidence among vaccinated (1.6) and naïve (26) individuals were compared. Therefore, the risk of SARS-CoV-2 infection following vaccination was less than one-tenth of the latter. Finally, vaccine recipients had no increased risk of breakthrough infection with the virus, as compared to those with a history of prior infection.

What are the implications?

The current study demonstrates that both prior infection and receipt of an mRNA vaccine confer a high degree of immunity against reinfection or breakthrough infections, respectively. This observation has also been described in other stories that reported the equivalent and high protective efficacy of vaccination with the BNT162b2 or ChAdOx1 nCOV-19 vaccines and prior infection with the virus.

This protection likely operates through both humoral and cellular arms of the adaptive immune response. The virus S protein and other antigens elicit specific and durable T cell responses targeting these epitopes. The diversity of the T cell response allows a breadth of protection against the ancestral SARS-CoV-2, as well as key variants of concern such as the B.1.1.7, B.1.351, and P.1 lineages.

Moreover, memory B cells have been detected that provide strong antibody-mediated immunity over the long term, up to six months after infection.

Combined with earlier studies, our findings should provide increased confidence that those previously infected are at very low risk for repeat infection."

A possibility to be ruled out by further study is the rise of new variants, which could be an alternative explanation for the low detection of the virus in this group caused by mutations that prevent recognition of the viral genetic material by the RT-PCR primer sequences.

*Important Notice

medRxiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information.

Journal reference:

Kojima, N., Roshani, A., Brobeck, M., et al. (2021). Incidence of Severe Acute Respiratory Syndrome Coronavirus-2 infection among previously infected or vaccinated employees. medRxiv. doi:10.1101/2021.07.03.21259976. ... 21259976v1
Posts: 3538
Joined: Fri Jun 26, 2020 5:22 am

Re: So what happened to people that got the C-19 , and now have the antibodies ?

Post by trader32176 »

'This Ends The Debate' - Israeli Study Shows Natural Immunity 13x More Effective Than Vaccines At Stopping Delta

8/28/21 ... s-stopping

Dr. Anthony Fauci and the rest of President Biden's COVID advisors have been proven wrong about "the science" of COVID vaccines yet again. After telling Americans that vaccines offer better protection than natural infection, a new study out of Israel suggests the opposite is true: natural infection offers a much better shield against the delta variant than vaccines.

The study was described by Bloomberg as "the largest real-world analysis comparing natural immunity - gained from an earlier infection - to the protection provided by one of the most potent vaccines currently in use." A few days ago, we noted how remarkable it was that the mainstream press was finally giving voice to scientists to criticize President Biden's push to start doling out booster jabs. Well, this study further questions the credibility of relying on vaccines, given that the study showed that the vaccinated were ultimately 13x as likely to be infected as those who were infected previously, and 27x more likely to be symptomatic.

Alex Berenson, a science journalist who has repeatedly questioned the efficacy of vaccines and masks at preventing COVID, touted the study as enough to "end any debate over vaccines v natural immunity."

Here's an excerpt from a report by Science Magazine:

The new analysis relies on the database of Maccabi Healthcare Services, which enrolls about 2.5 million Israelis. The study, led by Tal Patalon and Sivan Gazit at KSM, the system’s research and innovation arm, found in two analyses that people who were vaccinated in January and February were, in June, July, and the first half of August, six to 13 times more likely to get infected than unvaccinated people who were previously infected with the coronavirus. In one analysis, comparing more than 32,000 people in the health system, the risk of developing symptomatic COVID-19 was 27 times higher among the vaccinated, and the risk of hospitalization eight times higher.

This time, the data leave little doubt that natural infection truly is the better option for protection against the delta variant, despite the fact that the US won't acknowledge the already infected as having antibodies protecting them from the virus.

As the first country to achieve widepsread coverage by the vaccine, Israel is now in an unthinkable situation: daily case numbers have reached new record levels as the delta variant penetrates the vaccines' protection like a hot knife slicing through butter.

At the very least, the results of the study are good news for patients who have already successfully battled COVID but show the challenge of relying exclusively on immunizations to move past the pandemic.

"This analysis demonstrated that natural immunity affords longer lasting and stronger protection against infection, symptomatic disease and hospitalization due to the delta variant," the researchers said.

Unfortunately, the study also showed that any protection is time-limited. Protection offered by natural infection wanes over time, just like the protection afforded by vaccines: The risk of a vaccine-breakthrough delta case was 13x higher than the risk of developing a second infection when the original illness occurred during January or February 2021. That's significantly more than the risk for people who were ill earlier in the outbreak.

What's more, giving a single shot of the vaccine to those who had been previously infected also appeared to boost their protection. Still, the data don't tell us anything about the long-term benefits of booster doses.

This latest data showing the vaccines don't offer anywhere near the 90%+ protection that was originally advertised by the FDA after the emergency authorization. Other studies are finding harmful side effects caused by the mRNA jabs are also more prevalent than previously believed.

Read the study pre-print below:

2021.08.24.21262415v1.full by Joseph Adinolfi Jr. on Scribd
Posts: 3538
Joined: Fri Jun 26, 2020 5:22 am

Re: So what happened to people that got the C-19 , and now have the antibodies ?

Post by trader32176 »

In the immune arsenal, antibodies offer best long-term hope against COVID

9/3/21 ... covid.html

When it comes to long-lasting protection against COVID-19, antibodies are our biggest allies, a new Yale University study shows.

Since the emergence of the SARS-CoV-2 virus, the relative contributions of the different parts of our immune system arsenal—particularly those of T cells, which destroy infected cells from the inside, and B cells, which produce antibodies that clean up free-floating virus outside of cells—during and after infection has remained unclear.

To better understand, scientists in the lab of Yale's Akiko Iwasaki, the Waldemar Von Zedtwitz Professor of Immunobiology, conducted a series of experiments on mice to determine which immune system responses played the most important role at different stages of COVID-19 cases.

"While T cells play a role during acute infections, our antibodies are crucial for long-term protection against re-infection," said Benjamin Goldman-Israelow, a postdoctoral researcher in Iwasaki's lab and lead author of the study.

The paper was published Sept. 2 in the journal Science Immunology.

During acute infections, both types of adaptive, or learned, immune responses play key roles in combatting infections. Mice that lack T cells but have antibody protection and those without antibodies but that have healthy T cells both combatted infection equally well, researchers found.

However, in mice lacking what are known as "memory" T cells—a kind of reserve cell that remains in the body after infection—antibodies alone provided more than adequate protection after mice were reinfected with SARS-CoV-2, the virus that causes COVID-19, or the highly immune evasive Beta variant.

"Ultimately, generating robust mucosal immunity that involves both local antibodies and T cells will be key to preventing infection and disease," Iwasaki said.

More information: Benjamin Israelow et al, Adaptive immune determinants of viral clearance and protection in mouse models of SARS-CoV-2, Science Immunology (2021). DOI: 10.1126/sciimmunol.abl4509
Post Reply